PE20200676A1 - Composicion de cannabis - Google Patents

Composicion de cannabis

Info

Publication number
PE20200676A1
PE20200676A1 PE2019000308A PE2019000308A PE20200676A1 PE 20200676 A1 PE20200676 A1 PE 20200676A1 PE 2019000308 A PE2019000308 A PE 2019000308A PE 2019000308 A PE2019000308 A PE 2019000308A PE 20200676 A1 PE20200676 A1 PE 20200676A1
Authority
PE
Peru
Prior art keywords
fraction
weight
composition
cannabis composition
terpene fraction
Prior art date
Application number
PE2019000308A
Other languages
English (en)
Inventor
Harry Karelis
Mara Gordon
Stewart Smith
Stewart Washer
Original Assignee
Zelda Therapeutics Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=61072439&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20200676(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zelda Therapeutics Operations Pty Ltd filed Critical Zelda Therapeutics Operations Pty Ltd
Publication of PE20200676A1 publication Critical patent/PE20200676A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Abstract

Se refiere a una composicion farmaceutica topica que comprende un extracto de Cannabis que comprende al menos 75 % en peso de un cannabinoide principal (?9-Tetrahidrocannabinol (THC) o Cannabidiol (CBD); una fraccion de terpeno cuya fraccion comprende limoneno al menos 5,4% en peso de la fraccion de terpeno y un sistema de suministro topico que comprende dos o mas de aceite esencial de bergamota, de cedro, de manzanilla, entre otros. Dicha composicion es util en el tratamiento de un trastorno de la piel.
PE2019000308A 2016-08-03 2017-08-03 Composicion de cannabis PE20200676A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662370303P 2016-08-03 2016-08-03
PCT/AU2017/050815 WO2018023164A1 (en) 2016-08-03 2017-08-03 Cannabis composition

Publications (1)

Publication Number Publication Date
PE20200676A1 true PE20200676A1 (es) 2020-06-11

Family

ID=61072439

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2019000308A PE20200676A1 (es) 2016-08-03 2017-08-03 Composicion de cannabis

Country Status (11)

Country Link
US (2) US20190307719A1 (es)
EP (1) EP3493799A4 (es)
JP (1) JP2019523282A (es)
KR (1) KR20190033590A (es)
CN (1) CN109789124A (es)
AU (4) AU2017307644B2 (es)
CA (1) CA3031811A1 (es)
CL (1) CL2019000268A1 (es)
PE (1) PE20200676A1 (es)
SG (1) SG11201900596XA (es)
WO (1) WO2018023164A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109843287A (zh) 2016-08-03 2019-06-04 塞尔达治疗手术有限公司 大麻属组合物
AU2017307644B2 (en) 2016-08-03 2019-06-20 Zelira Therapeutics Operations Pty Ltd Cannabis composition
BR112019001794A2 (pt) 2016-08-03 2019-05-07 Zelda Therapeutics Operations Pty Ltd composição de cannabis
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US11484510B2 (en) * 2017-08-28 2022-11-01 Apirx Pharmaceutical Usa, Llc Method to treat vitiligo
US11202771B2 (en) 2018-01-31 2021-12-21 Treehouse Biotech, Inc. Hemp powder
EP3793542A4 (en) * 2018-05-14 2022-03-30 Buzzelet Development And Technologies Ltd TERPENE-ENRICHED CANNABINOID COMPOSITIONS AND THEIR USES IN THE TREATMENT OF INFECTIOUS DISEASES
US10736869B2 (en) * 2018-07-16 2020-08-11 ECS Health Sciences, Inc. Compositions and methods related to cannabinoids, terpenoids and essential oils
US11013715B2 (en) * 2018-07-19 2021-05-25 Vertosa, Inc. Nanoemulsion hydrophobic substances
IL261774B (en) * 2018-09-13 2020-04-30 Unv Medicine Ltd Compositions for treating dermatological conditions
EP3864000A4 (en) 2018-10-10 2022-08-10 Treehouse Biosciences, Inc. CANNABIGEROL SYNTHESIS
WO2020086291A1 (en) * 2018-10-22 2020-04-30 Jones Lisa Marie Topical compositions incorporating cannabis
WO2020123383A1 (en) * 2018-12-10 2020-06-18 Natural Extraction Systems, LLC Compositions with novel cannabinoid and terpene profiles
WO2020129045A1 (en) * 2018-12-19 2020-06-25 Pathway RX Inc. Novel cannabis lines and extracts for treating skin disorders
WO2020129044A1 (en) * 2018-12-19 2020-06-25 Pathway RX Inc. Novel cannabis lines and extracts for skin rejuvenation and skin protection
WO2020129043A1 (en) * 2018-12-19 2020-06-25 Pathway RX Inc. Novel cannabis sativa lines and extracts with anti-cancer properties
US20220054380A1 (en) * 2018-12-25 2022-02-24 Epm (Ip), Inc. Cannabidioloic acid esters for cosmetic or edible compositions
EP3906025A4 (en) * 2019-01-04 2022-09-21 Columbia Care LLC CANNABINOID TOPICAL FORMULATIONS
US11246310B2 (en) * 2019-02-08 2022-02-15 Global Biolife Inc. Insect repelling composition
US20200345686A1 (en) * 2019-04-30 2020-11-05 Vcp Ip Holdings, Llc, Limited Liability Company Delaware Compositions and methods for treating skin and neuropathic conditions and disorders
US10717056B1 (en) 2019-09-09 2020-07-21 Michael Cem Gokay Method and apparatus for purification of cannabinoid extracts
US20210093539A1 (en) * 2019-09-30 2021-04-01 Concept Matrix Solutions Topical cosmetic
US20210113490A1 (en) * 2019-10-21 2021-04-22 Avicanna Inc. Topical cannabinoid compositions for clear skin
US10941131B1 (en) * 2019-10-28 2021-03-09 Pure Tonic Concentrates, LLC Conversion of cannabidiol or delta-9 tetrahydrocannabinolic acid to delta-9 tetrahydrocannabinol and delta-8 tetrahydrocannabinol in nontoxic heterogeneous mixtures
WO2021127559A1 (en) * 2019-12-19 2021-06-24 Natural Extraction Systems, LLC Compositions comprising cannabinoid anions and anti-nucleating agents
US11590187B2 (en) * 2020-01-14 2023-02-28 Shaman Naturals, Llc Antimicrobial compositions
US20210346276A1 (en) * 2020-05-05 2021-11-11 Gm Pharmaceuticals, Inc. Skincare compositions containing cannabidiol
US20210369802A1 (en) * 2020-06-01 2021-12-02 James Chuang Cannabis plant formulations and methods of delivery
US20220054446A1 (en) * 2020-08-18 2022-02-24 Yvette Rose Webb Targeted treatment with a topical cream of cannabinoids, terpenes, and essential oils
WO2023152748A1 (en) * 2022-02-13 2023-08-17 Reagenics Research Ltd. Plant-based skin preparations and use thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949582B1 (en) * 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
DE10051427C1 (de) * 2000-10-17 2002-06-13 Adam Mueller Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte
JP2004002237A (ja) * 2002-05-31 2004-01-08 Noriko Yagi 老化防止ハーブ
EP1559423A1 (en) * 2004-02-02 2005-08-03 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Medicinal acidic cannabinoids
GB2478595B (en) * 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
HUE026929T2 (en) * 2010-10-19 2016-08-29 Parenteral A S Composition for treating inflammatory diseases comprising boswellic acids and cannabidol
US20120264818A1 (en) * 2011-04-15 2012-10-18 Jon Newland Topical Compositions with Cannabis Extracts
US20130184354A1 (en) * 2012-01-13 2013-07-18 Donna K. Jackson Silicone and Hylauronic Acid (HLA) Delivery Systems for Products by Sustainable Processes for Medical Uses Including Wound Management
US20130274321A1 (en) * 2012-03-30 2013-10-17 Jon Newland Topical Compositions with Cannabis Extracts
PL2844243T3 (pl) * 2012-05-03 2020-05-18 Echo Pharmaceuticals B.V. Sposób przygotowania izolatu z rośliny konopi zawierającego delta-9-tetrahydrokannabinol
EP2934512B1 (en) * 2012-12-18 2021-11-24 Kotzker Consulting LLC Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
CA2904968A1 (en) * 2013-03-14 2014-10-02 Sc Laboratories, Inc. Bioactive concentrates and uses thereof
US9095554B2 (en) * 2013-03-15 2015-08-04 Biotech Institute LLC Breeding, production, processing and use of specialty cannabis
EP3049076A4 (en) * 2013-09-26 2018-04-18 Ronald D. Sekura Topical treatments incorporating cannabis sp. derived botanical drug product
EP3062606B1 (en) * 2013-10-29 2019-03-20 Biotech Institute, LLC Breeding, production, processing and use of specialty cannabis
JP6377423B2 (ja) * 2014-06-17 2018-08-22 ロート製薬株式会社 外用組成物
CA3111682A1 (en) * 2014-06-26 2015-12-30 Island Breeze Systems Ca, Llc Mdi related products and methods of use
EP3217995A1 (en) * 2014-08-25 2017-09-20 Janing Holding ApS Device with compositions for delivery to the lungs, the oral mucosa and the brain
CA2859930A1 (en) * 2014-09-22 2016-03-22 Antony Paul Hornby A cannabis topical from heat treated cocount oil
EP3209312A1 (en) * 2014-10-21 2017-08-30 United Cannabis Corp. Cannabis extracts and methods of preparing and using same
US20160309774A1 (en) * 2015-04-27 2016-10-27 Michael D. Wand Terpene carrier
AU2016359160A1 (en) * 2015-11-24 2018-06-14 Constance Therapeutics, Inc. Cannabis oil compositions and methods for preparation thereof
AU2016367036B2 (en) * 2015-12-09 2019-04-18 Poviva Corp. Methods for formulating orally ingestible compositions comprising lipophilic active agents
AU2017210319A1 (en) * 2016-01-20 2018-08-23 Flurry Powders, Llc Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
IL307857A (en) * 2016-03-16 2023-12-01 Buzzelet Development And Technologies Ltd Cannobinoid compounds are rich in terpenes
IL246790A0 (en) * 2016-07-14 2016-09-29 Friedman Doron Self-dissolving compounds of cannabinoids
AU2017307644B2 (en) 2016-08-03 2019-06-20 Zelira Therapeutics Operations Pty Ltd Cannabis composition

Also Published As

Publication number Publication date
AU2017307644A1 (en) 2018-07-05
CN109789124A (zh) 2019-05-21
EP3493799A1 (en) 2019-06-12
WO2018023164A1 (en) 2018-02-08
CL2019000268A1 (es) 2019-10-04
US20220362208A1 (en) 2022-11-17
US20190307719A1 (en) 2019-10-10
AU2021240296B2 (en) 2024-03-07
EP3493799A4 (en) 2020-04-01
SG11201900596XA (en) 2019-02-27
AU2017307644B2 (en) 2019-06-20
KR20190033590A (ko) 2019-03-29
CA3031811A1 (en) 2018-02-08
AU2019208177A1 (en) 2019-08-08
AU2018100921A4 (en) 2018-08-02
AU2021240296A1 (en) 2021-10-28
AU2019208177B2 (en) 2021-07-01
JP2019523282A (ja) 2019-08-22
AU2018100921B4 (en) 2019-02-14

Similar Documents

Publication Publication Date Title
PE20200676A1 (es) Composicion de cannabis
PE20200726A1 (es) Composicion de cannabis
CL2020003368A1 (es) Composicion y metodo para tratar el dolor
PE20201163A1 (es) Composiciones y tratamientos para el trastorno del sueno
PE20230607A1 (es) Composicion de cannabis
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
CO2017004974A2 (es) Extractos de cannabis y métodos de preparación.
HRP20201230T1 (hr) Uporaba kanabinoida u liječenju atoničkih napadaja kod lennox-gastaut sindroma
IN2014DN09507A (es)
CL2017002335A1 (es) Composiciones de cosmetica topica para combatir radicales libres
MX2019000427A (es) Formas de dosificacion oral de cannabinoide de alta concentracion.
BR112015019657A2 (pt) composições tópicas e métodos de uso das mesmas
LT2016046A (lt) Aliejinio gelio kompozicija su aktyviausiais junginiais iš c. sativa ir m. arvensis ir jos pateikimo sistema, skirta giliųjų audinių uždegimo ir skausmo mažinimui
BR112014023379A8 (pt) Microemulsões com base em ciclodextrina e usos dermatológicos das mesmas
BR112017025221A2 (pt) composições cosméticas compreendendo esclareolida
BR112014029762A2 (pt) composição contendo n-metil-n-acilglucamina
GB201211639D0 (en) Cannabinoids for use in the treatment of neurodegenative diseases or disorders
PE20200338A1 (es) Composiciones cannabinoides novedosas y metodos para tratar la epilepsia infantil
CL2020003373A1 (es) Composición y método de ahorro de opiáceos
CL2019000198A1 (es) Nuevas formulaciones y composiciones de cannabis en comprimidos y métodos para su elaboración.
CO2021001059A2 (es) Composición de cannabinoides y método para tratar el ptsd y/o la ansiedad
CL2016002276A1 (es) Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad
CL2015000039A1 (es) Derivados estra-1,3,5(10),16-tetraeno-3-sustituidos, preparaciones farmacéuticas que los comprenden y su uso en la preparación de medicamentos para tratar la endometriosis.
BR112018012952A2 (pt) composições para higiene pessoal
MX2020004232A (es) Composiciones de cannabinoides y sus metodos de uso.